J. Deese

发表

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.

Michel Alary, Doug Taylor, B S Pradeep, 2008, The New England journal of medicine.

Preexposure prophylaxis for HIV infection among African women.

Katrien Fransen, Douglas J. Taylor, Amy Corneli, 2012, The New England journal of medicine.

Lessons learnt from implementing an empirically informed recruitment approach for FEM-PrEP, a large HIV prevention clinical trial

J. Odhiambo, C. Wong, K. Agot, 2014 .

Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study

L. van Damme, L. Bekker, H. Jaspan, 2018, Sexually Transmitted Infections.

Intermediate vaginal flora and bacterial vaginosis are associated with the same factors: findings from an exploratory analysis among female sex workers in Africa and India

L. van Damme, M. Becker, M. Alary, 2013, Sexually Transmitted Infections.

Intermediate vaginal flora is associated with HIV prevalence as strongly as bacterial vaginosis in a cross-sectional study of participants screened for a randomised controlled trial

L. van Damme, M. Becker, M. Alary, 2012, Sexually Transmitted Infections.

ART initiation among women newly diagnosed with HIV in a contraceptive trial in sub-Saharan Africa

R. Heffron, M. Beksinska, M. Onono, 2021, AIDS care.

Detection of new HIV infections in a multicentre HIV antiretroviral pre-exposure prophylaxis trial.

L. van Damme, K. Fransen, T. Crucitti, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant

C. Morrison, J. Baeten, H. Rees, 2020, Sexually Transmitted Infections.

Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report

L. van Damme, R. Burnett, J. Deese, 2015, Journal of Medical Case Reports.

FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis

L. van Damme, S. Kapiga, K. Agot, 2014, Journal of acquired immune deficiency syndromes.

Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women

Douglas J. Taylor, L. van Damme, R. Grant, 2015, AIDS.

Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial

Douglas J. Taylor, L. van Damme, J. Deese, 2014, BMC Pharmacology and Toxicology.

Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya.

L. van Damme, D. Hubacher, J. Deese, 2015, Contraception.

Age-Specific Risk Scores Do Not Improve HIV-1 Prediction Among Women in South Africa

C. Morrison, J. Baeten, R. Heffron, 2020, Journal of acquired immune deficiency syndromes.

Recent Advances and New Challenges in Cisgender Women’s Gynecologic and Obstetric Health in the Context of HIV

R. Heffron, H. Jaspan, Lindi Masson, 2021, Clinical obstetrics and gynecology.

Injectable Progestin‐Only Contraception is Associated With Increased Levels of Pro‐Inflammatory Cytokines in the Female Genital Tract

C. Morrison, L. van Damme, Lindi Masson, 2015, American journal of reproductive immunology.

Inflammation of Innate Immune Responses in the Female Genital Tract: Association with Use of Injectable Progestin-Only Contraception, Reproductive Tract Infections and Risk of HIV Acquisition

J. Deese, 2015 .

Prevalence and Incidence Estimation of HSV-2 by Two IgG ELISA Methods among South African Women at High Risk of HIV

L. van Damme, J. Menten, T. Crucitti, 2015, PloS one.

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial

N. Veiga, L. Bahamondes, J. Deese, 2022, EClinicalMedicine.

A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.

C. Morrison, Pai-Lien Chen, C. Kwok, 2018, AIDS research and human retroviruses.

Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives

C. Morrison, J. Deese, Subarna Pradhan, 2018, Open access journal of contraception.

Genital inflammatory status and the innate immune response to contraceptive initiation

C. Morrison, M. Beksinska, A. Williamson, 2022, American journal of reproductive immunology.

What's sex got to do with it? Understanding potential confounding and exposure misclassification in mechanistic sexually transmitted infection research.

Pai-Lien Chen, J. Nelson, M. Hobbs, 2020, The Journal of infectious diseases.

Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial

L. van Damme, M. Becker, M. Alary, 2013, BMC Infectious Diseases.

Acceptability of the contraceptive Sayana® Press when injected every four months: Results from a 12-month trial in Brazil, Chile and the Dominican Republic.

N. Veiga, L. Bahamondes, J. Deese, 2022, Contraception.

Performance of serological and molecular tests within acute HIV infection.

L. van Damme, K. Fransen, T. Crucitti, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Verification of chemistry reference ranges using a simple method in sub-Saharan Africa

Douglas J. Taylor, L. van Damme, T. Crucitti, 2016, African journal of laboratory medicine.

Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial

R. Heffron, H. Jaspan, M. Onono, 2022, AIDS and Behavior.

Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial

C. Morrison, J. Baeten, R. Heffron, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression

C. Morrison, J. Baeten, R. Heffron, 2020, AIDS research and human retroviruses.

Return to ovulation after Sayana Press is injected every 4 months for one year: Empirical and pharmacokinetic/pharmacodynamic modeling results

L. Bahamondes, D. Taylor, J. Deese, 2022, Contraception: X.

Preexposure prophylaxis for HIV infection among African women.

Douglas J. Taylor, L. van Damme, S. Kapiga, 2012, The New England journal of medicine.

Detection of new HIV infections in a multicentre HIV antiretroviral pre-exposure prophylaxis trial.

L. van Damme, K. Fransen, T. Crucitti, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Injectable Progestin‐Only Contraception is Associated With Increased Levels of Pro‐Inflammatory Cytokines in the Female Genital Tract

C. Morrison, L. van Damme, Lindi Masson, 2015, American journal of reproductive immunology.